The Venture Codex Logo

The Venture Codex

Overview

Macromolecular pharmaceutical contract development and manufacturing.

Total Raised

$170 M

Rounds

2

Links

Verticals

Biotechnology
Manufacturing
Pharmaceutical

Investment History

  1. Series C

    Jan 2022

    $100M

  2. Series B

    Mar 2021

    $70M

Team

Jianxin Chen

Founder & CEO

Weidong Hao

Chief Scientific Officer,Senior Vice President of Operation

Lei Lei

Scientist